Related Experiment Video
Updated: Jul 26, 2025
06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
1.4K
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Zhuangling Lin1, Lijuan Tang2, Shuxia Chen2
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China, 1551136950@qq.com.
Ophthalmic Research
|June 13, 2023
Summary
Enhancer of zeste homolog 2 (EZH2) is highly expressed in most retinoblastoma (RB) tumors. This elevated EZH2 expression correlates with increased tumor cell proliferation, suggesting EZH2 as a potential therapeutic target for RB.
Area of Science:
- Oncology
- Molecular Biology
- Ophthalmology
Background:
- Enhancer of zeste homolog 2 (EZH2) is a key regulator of cell-cycle progression.
- EZH2 is part of the polycomb repressive complex 2 (PRC2).
- Increased EZH2 expression is implicated in various cancers, including retinoblastoma (RB).
Purpose of the Study:
- To investigate EZH2 expression levels in retinoblastoma (RB) tissues.
- To correlate EZH2 expression with clinicopathological parameters in RB.
- To assess the relationship between EZH2 expression and tumor cell proliferation.
Main Methods:
- Retrospective analysis of 99 enucleated RB cases.
- Immunohistochemistry used to detect EZH2 and Ki67 expression.
- Statistical analysis to determine correlations.
Main Results:
- High EZH2 expression (≥70% positive rate) observed in 92 out of 99 RB cases.
- EZH2 was detected in tumor cells but not in normal retinal tissues.
- A significant positive correlation found between EZH2 and Ki67 expression (r = 0.65, p < 0.001).
Conclusions:
- Most retinoblastoma (RB) cases exhibit elevated EZH2 expression.
- EZH2 expression is linked to increased tumor cell proliferation in RB.
- EZH2 represents a potential therapeutic target for retinoblastoma.
Related Concept Videos
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K